| dc.contributor.author | Prohászka Zoltán | |
| dc.contributor.author | Tóth Ferenc D. | |
| dc.contributor.author | Banhegyi Dénes | |
| dc.contributor.author | Füst George | |
| dc.date.accessioned | 2019-01-11T12:08:14Z | |
| dc.date.available | 2019-01-11T12:08:14Z | |
| dc.date.issued | 1997 | |
| dc.identifier.citation | pagination=296-302; journalVolume=3; journalIssueNumber=4; journalTitle=PATHOLOGY AND ONCOLOGY RESEARCH; | |
| dc.identifier.uri | http://repo.lib.semmelweis.hu//handle/123456789/6387 | |
| dc.description.abstract | In humans the HIV infection results in a chronic disease with a permanent fight between factors controlling HIV and the escape of the virus. Fromthese control mechanisms the present review summarizes the role betwen complement and autoantibodies; the competition of complement and anti-HIV antibodies for binding sites, the role of mannan-binding lectin in the susceptibility to and in the survival after HIV infection, the contribution of complement-dependent enhancing type antibodies to the clinical progression of HIV disease as well as the changing pattern of some autoantibodies (mimicking MHC class II molecules, anti-heat shock protein 60 antibodies and anti-C1q antibodies) which were found to correlate to immunological and clinical parameters. | |
| dc.relation.ispartof | urn:issn:1219-4956 | |
| dc.title | Role of Complement and Antibodies in the Control and Facilitation of HIV Disease. | |
| dc.type | Journal Article | |
| dc.date.updated | 2018-09-02T10:19:29Z | |
| dc.language.rfc3066 | en | |
| dc.identifier.mtmt | 1233463 | |
| dc.identifier.pubmed | 11173651 | |
| dc.contributor.department | SE/AOK/K/III. Sz. Belgyógyászati Klinika | |
| dc.contributor.institution | Semmelweis Egyetem |